Use the following sample data for the next questions. A study by Medtronic, a
manufacturer of a cardiac resynchronization device, on 813 patients with severe
heart failure yielded the following data:
-Find the value of the absolute risk reduction for patients hospitalized or died in the drug therapy and the drugs with electrical cardiac device groups.